Showing results (51-60 of 64) with videos related to
Sort By:
Pageof 7
Acta Medica Okayama|January 10, 2008
Ectopic varices rupture in the gastroduodenal anastomosis successfully treated with N-butyl-2-cyanoacrylate injectionYasuhiro Onozato, Satoru Kakizaki, Haruhisa Iizuka, et al.Internal Medicine (Tokyo, Japan)|October 4, 2021
Follow-up after Direct-acting Antiviral Treatment for Chronic Hepatitis C Virus Infection: Most Patients Are Followed AppropriatelyHiroki Tojima, Satoru Kakizaki, Satoshi Takakusagi, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|November 22, 2019
Favorable outcome of retreatment by direct-acting antivirals for hepatitis C patients with daclatasvir plus asunaprevir combination therapy failureHiroki Tojima, Satoru Kakizaki, Satoshi Takakusagi, et al.Journal of Radiation Research|May 26, 2021
Long-term clinical outcomes of patients receiving proton beam therapy for caudate lobe hepatocellular carcinomaTakashi Iizumi, Toshiyuki Okumura, Yuta Sekino, et al.Cancers|June 12, 2026
Safety and Efficacy of Stereotactic Body Radiation Therapy in Very Elderly Patients (≥80 Years) with Solitary Hepatocellular CarcinomaYuki Tamura, Hiroki Tojima, Daichi Takizawa, et al.Current Oncology (Toronto, Ont.)|March 27, 2026
Efficacy of Lenvatinib as Second-Line Therapy After Atezolizumab Plus Bevacizumab for Hepatocellular CarcinomaDaichi Takizawa, Hirotaka Arai, Mitsuhiko Shibasaki, et al.Oncology|December 6, 2020
The Role of the Albumin-Bilirubin Score for Predicting the Outcomes in Japanese Patients with Advanced Hepatocellular Carcinoma Treated with Ramucirumab: A Real-World StudyTakeshi Hatanaka, Atsushi Naganuma, Mitsuhiko Shibasaki, et al.BMC Cancer|October 17, 2019
Randomized, phase II trial of sequential hepatic arterial infusion chemotherapy and sorafenib versus sorafenib alone as initial therapy for advanced hepatocellular carcinoma: SCOOP-2 trialMasaaki Kondo, Manabu Morimoto, Satoshi Kobayashi, et al.Molecular and Clinical Oncology|April 18, 2017
Clinical features of hemodialysis patients treated for hepatocellular carcinoma: Comparison between resection and radiofrequency ablationAtsushi Hiraoka, Takashi Kumada, Kojiro Michitaka, et al.Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|September 8, 2017
Characteristics and Prognosis of Hepatocellular Carcinoma in Japanese Patients Undergoing DialysisHidenori Toyoda, Atsushi Hiraoka, Toshifumi Tada, et al.Pageof 7